1. Home
  2. BANX vs STXS Comparison

BANX vs STXS Comparison

Compare BANX & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ArrowMark Financial Corp.

BANX

ArrowMark Financial Corp.

HOLD

Current Price

$19.71

Market Cap

154.9M

Sector

Finance

ML Signal

HOLD

Logo Stereotaxis Inc.

STXS

Stereotaxis Inc.

HOLD

Current Price

$1.93

Market Cap

182.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BANX
STXS
Founded
N/A
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
154.9M
182.3M
IPO Year
2013
2004

Fundamental Metrics

Financial Performance
Metric
BANX
STXS
Price
$19.71
$1.93
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.00
AVG Volume (30 Days)
34.8K
392.5K
Earning Date
01-01-0001
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
16.67
EPS
N/A
N/A
Revenue
N/A
$29,346,617.00
Revenue This Year
N/A
$28.22
Revenue Next Year
N/A
$30.47
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.45
$1.74
52 Week High
$23.67
$3.59

Technical Indicators

Market Signals
Indicator
BANX
STXS
Relative Strength Index (RSI) 55.58 50.57
Support Level $19.22 $1.74
Resistance Level $19.95 $1.99
Average True Range (ATR) 0.27 0.09
MACD 0.01 -0.00
Stochastic Oscillator 63.70 47.22

Price Performance

Historical Comparison
BANX
STXS

About BANX ArrowMark Financial Corp.

ArrowMark Financial Corp is a non-diversified, closed-end management investment company. Its objective is to provide stockholders with current income, and to a lesser extent capital appreciation. The company's investments in various portfolios such as debt securities, Trust Preferred and Preferred Securities, preferred securities, exchange-traded funds, money market funds and others.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: